Di Francesco, Angela Maria
Di Francesco, Angela Maria
Metabolic modification in gastrointestinal cancer stem cells: characteristics and therapeutic approaches
2016 Di Francesco, Angela Maria; Toesca Di Castellazzo, Amelia; Cenciarelli, C; Giordano, Alessandro; Gasbarrini, Antonio; Puglisi, Maria Ausiliatrice
High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells
2015 Puglisi, Maria Ausiliatrice; Cenciarelli, Carlo; Tesori, Valentina; Cappellari, Marianna; Martini, Maurizio; Di Francesco, Angela Maria; Giorda, Ezio; Carsetti, Rita; Ricci Vitiani, Lucia; Gasbarrini, Antonio
Resistance to the atypical retinoid ST1926 in SK-N-AS cells selected the subline rAS-ST with enhanced sensitivity to ATRA mediated by not conventional mechanisms: DNA damage, G2 accumulation and late telomerase inhibition
2015 Di Francesco, Angela Maria; Cusano, Gabriella; Franzese, O.; Orienti, I.; Falconi, M.; Vesci, L.; Riccardi, Riccardo
Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models
2012 Meco, Daniela; Di Francesco, Angela Maria; Cusano, G; Bucci, F; Pierri, Filomena; Patriarca, V; Torella, Ar; Pisano, C; Riccardi, Riccardo
Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity.
2008 Valli, C; Paroni, G; Paroni, G; Di Francesco, Angela Maria; Riccardi, Riccardo; Tavecchio, M; Erba, Eugenio; Boldetti, A; Gianni', M; Fratelli, M; Pisano, Claudio; Merlini, L; Antoccia, A; Cenciarelli, C; Terao, M; Garattini, E.
The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: a comparative study with SN38 and topotecan.
2005 Di Francesco, Angela Maria; Riccardi, Anna Shirley; Barone, Giuseppe; Rutella, Sergio; Meco, Daniela; Frapolli, Roberta; Zucchetti, Massimo; D'Incalci, Maurizio; Pisano, Claudio; Carminati, Paolo; Riccardi, Riccardo
The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: a comparative study with SN38 and topotecan.
2005 Di Francesco, Angela Maria; Riccardi, Anna Shirley; Barone, Giuseppe; Rutella, Sergio; Meco, Daniela; Frapolli, R; Zucchetti, M; D'Incalci, M; Pisano, C; Carminati, P; Riccardi, Riccardo
Variolin B and its derivate deosyvariolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity
2005 Simone, M; Erba, E; Damia, E; Vikhanskaya, F; Di Francesco, Angela Maria; Riccardi, Riccardo; Bailly, C; Cuevas, C; Fernandez Sousa Faro, Jm; D'Incalci, Maurizio
Cellular and molecular aspects of drugs of the future: oxaliplatin
2002 Riccardi, Riccardo; Di Francesco, Angela Maria; Ruggiero, Antonio
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2016 | Metabolic modification in gastrointestinal cancer stem cells: characteristics and therapeutic approaches | Di Francesco, Angela Maria; Toesca Di Castellazzo, Amelia; Cenciarelli, C; Giordano, Alessandro; Gasbarrini, Antonio; Puglisi, Maria Ausiliatrice | |
| 1-gen-2015 | High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells | Puglisi, Maria Ausiliatrice; Cenciarelli, Carlo; Tesori, Valentina; Cappellari, Marianna; Martini, Maurizio; Di Francesco, Angela Maria; Giorda, Ezio; Carsetti, Rita; Ricci Vitiani, Lucia; Gasbarrini, Antonio | |
| 1-gen-2015 | Resistance to the atypical retinoid ST1926 in SK-N-AS cells selected the subline rAS-ST with enhanced sensitivity to ATRA mediated by not conventional mechanisms: DNA damage, G2 accumulation and late telomerase inhibition | Di Francesco, Angela Maria; Cusano, Gabriella; Franzese, O.; Orienti, I.; Falconi, M.; Vesci, L.; Riccardi, Riccardo | |
| 1-gen-2012 | Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models | Meco, Daniela; Di Francesco, Angela Maria; Cusano, G; Bucci, F; Pierri, Filomena; Patriarca, V; Torella, Ar; Pisano, C; Riccardi, Riccardo | |
| 1-gen-2008 | Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity. | Valli, C; Paroni, G; Paroni, G; Di Francesco, Angela Maria; Riccardi, Riccardo; Tavecchio, M; Erba, Eugenio; Boldetti, A; Gianni', M; Fratelli, M; Pisano, Claudio; Merlini, L; Antoccia, A; Cenciarelli, C; Terao, M; Garattini, E. | |
| 1-gen-2005 | The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: a comparative study with SN38 and topotecan. | Di Francesco, Angela Maria; Riccardi, Anna Shirley; Barone, Giuseppe; Rutella, Sergio; Meco, Daniela; Frapolli, Roberta; Zucchetti, Massimo; D'Incalci, Maurizio; Pisano, Claudio; Carminati, Paolo; Riccardi, Riccardo | |
| 1-gen-2005 | The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: a comparative study with SN38 and topotecan. | Di Francesco, Angela Maria; Riccardi, Anna Shirley; Barone, Giuseppe; Rutella, Sergio; Meco, Daniela; Frapolli, R; Zucchetti, M; D'Incalci, M; Pisano, C; Carminati, P; Riccardi, Riccardo | |
| 1-gen-2005 | Variolin B and its derivate deosyvariolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity | Simone, M; Erba, E; Damia, E; Vikhanskaya, F; Di Francesco, Angela Maria; Riccardi, Riccardo; Bailly, C; Cuevas, C; Fernandez Sousa Faro, Jm; D'Incalci, Maurizio | |
| 1-gen-2002 | Cellular and molecular aspects of drugs of the future: oxaliplatin | Riccardi, Riccardo; Di Francesco, Angela Maria; Ruggiero, Antonio |